A study to assess the pharmacokinetics and safety of single doses of Anifrolumab in healthy subjects

Trial Identifier: D3461C00006
Sponsor: AstraZeneca
NCTID:: NCT02601625
Start Date: November 2015
Primary Completion Date: May 2016
Study Completion Date: May 2016
Condition: Healthy Volunteers; Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, MD Baltimore, MD, United States of America, 21225